Enterococcus faecium T-110
Enterococcus faecium T-110 is one component of a three-strain probiotic combination that has been studied in animal models, including a germ-free mouse study examining neurogenesis (the formation of new nerve cells) and a rat model of chronic kidney disease. It is not possible from these studies to attribute specific effects to T-110 alone. Strain-specific human clinical evidence for E. faecium T-110 is currently absent, and broader human safety and efficacy data have not been established. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 3 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 1 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
4 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 39676242 →Combination of 3 probiotics restores attenuated adult neurogenesis in germ-free mice· Stem Cells · 2024
-
[2]
PMID 36996047 →Ameliorating effect of probiotics in a rat model of chronic kidney disease· PLoS ONE · 2023
-
[3]
PMID 37016687 →Bacillus subtilis TO-A extends the lifespan of Caenorhabditis elegans· Bioscience of Microbiota Food and Health · 2023